product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
TIF1β (C42G12) Rabbit mAb
catalog :
4124
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
C42G12
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; mouse; 1:1000; fig s6
  • western blot; mouse; fig s3
Hartlerode A, Morgan M, Wu Y, Buis J, Ferguson D. Recruitment and activation of the ATM kinase in the absence of DNA-damage sensors. Nat Struct Mol Biol. 2015;22:736-43 pubmed publisher
Yu J, Chen L, Cui B, Wu C, Choi M, Chen Y, et al. Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib. Leukemia. 2017;31:1333-1339 pubmed publisher
Sun R, Liang D, Gao Y, Lan K. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency. J Virol. 2014;88:7331-44 pubmed publisher
product information
SKU :
4124S
Product-Name :
TIF1β (C42G12) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Flow cytometry
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
100
Host :
Rabbit
Target :
TIF1b
Primary-Protein :
TIF1B
Alt-Names :
FLJ29029,KAP-1,KAP1,KRAB-associated protein 1,KRAB-interacting protein 1,KRIP-1,Nuclear corepressor KAP-1,RING finger protein 96,RNF96,TF1B,TIF1-beta,TIF1B,TRIM28,Transcription intermediary factor 1-beta,Tripartite motif-containing protein 28,transcriptional intermediary factor 1-beta,tripartite motif-containing 28
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.